| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 118,9 k € | +12.9% | 105,3 k € | +2.0% | 103,3 k € | +6.4% | 97,0 k € | +42.7% | 68,0 k € | -2.2% | 69,5 k € | -0.3% | 69,7 k € | -1.2% | 70,6 k € | -7.4% | 76,2 k € | -2.5% | 78,1 k € | -6.8% | 83,9 k € | +1.8% | 82,3 k € | -2.4% | 84,4 k € | -0.3% | 84,7 k € | -0.3% | 85,0 k € | +0.5% | 84,6 k € | -3.9% | 88,0 k € | +0.4% | 87,7 k € | -1.0% | 88,6 k € | -6.0% | 94,3 k € | |
| EBITDA | 118,6 k € | +13.5% | 104,5 k € | +1.4% | 103,0 k € | +7.1% | 96,2 k € | +43.0% | 67,2 k € | -2.5% | 68,9 k € | -0.2% | 69,1 k € | -1.3% | 70,0 k € | -8.0% | 76,0 k € | -2.7% | 78,1 k € | -6.8% | 83,9 k € | +1.8% | 82,3 k € | -2.4% | 84,4 k € | -0.3% | 84,7 k € | -0.3% | 85,0 k € | +0.5% | 84,6 k € | -3.9% | 88,0 k € | +0.4% | 87,7 k € | -1.0% | 88,6 k € | -6.0% | 94,3 k € | |
| Operating profit | 108,9 k € | +6.7% | 102,0 k € | -1.0% | 103,0 k € | +7.1% | 96,2 k € | +60.5% | 59,9 k € | -2.8% | 61,6 k € | -0.2% | 61,8 k € | -1.5% | 62,7 k € | -8.8% | 68,7 k € | -12.0% | 78,1 k € | -6.8% | 83,9 k € | +1.8% | 82,3 k € | -2.4% | 84,4 k € | -0.3% | 84,7 k € | -0.3% | 85,0 k € | +0.5% | 84,6 k € | -3.9% | 88,0 k € | +0.4% | 87,7 k € | -1.0% | 88,6 k € | -6.0% | 94,3 k € | |
| Profit/loss | 86,7 k € | +41.6% | 61,2 k € | -24.7% | 81,3 k € | +2.3% | 79,5 k € | +26.8% | 62,7 k € | -2.9% | 64,5 k € | +128.2% | 28,3 k € | +5.6% | 26,8 k € | -56.8% | 62,0 k € | -27.8% | 85,8 k € | +38.9% | 61,8 k € | -7.9% | 67,1 k € | -0.8% | 67,6 k € | +1.5% | 66,6 k € | +1.1% | 65,8 k € | +6.8% | 61,6 k € | -0.4% | 61,9 k € | +3.6% | 59,7 k € | +1.1% | 59,1 k € | -3.3% | 61,1 k € | |
| Equity | 621,6 k € | +10.3% | 563,6 k € | +6.5% | 529,1 k € | +11.8% | 473,4 k € | -4.3% | 494,5 k € | -2.5% | 507,4 k € | +14.2% | 444,5 k € | +6.5% | 417,2 k € | -53.3% | 894,2 k € | +2.8% | 869,5 k € | +5.9% | 820,9 k € | +3.1% | 796,3 k € | +227.5% | 243,2 k € | -67.6% | 749,7 k € | +7.3% | 698,9 k € | +7.7% | 648,9 k € | +7.6% | 603,1 k € | +8.3% | 557,0 k € | +8.6% | 513,1 k € | +9.2% | 469,9 k € | |
| Total assets | 1,2 M € | +3.7% | 1,2 M € | +9.5% | 1,1 M € | +4.6% | 1,0 M € | -1.5% | 1,0 M € | +3.5% | 1,0 M € | +3.0% | 983,9 k € | +4.9% | 938,1 k € | -9.4% | 1,0 M € | +4.5% | 991,6 k € | +8.2% | 916,2 k € | +1.9% | 899,0 k € | -37.7% | 1,4 M € | +51.0% | 955,2 k € | +1.7% | 939,7 k € | +1.6% | 924,6 k € | +1.1% | 914,4 k € | -3.3% | 945,3 k € | +0.8% | 938,2 k € | +0.8% | 930,6 k € | |
| Cash | 70,8 k € | +50.9% | 46,9 k € | +44.8% | 32,4 k € | +40.6% | 23,1 k € | -83.9% | 142,9 k € | +43.8% | 99,4 k € | +68.1% | 59,1 k € | +90.0% | 31,1 k € | -50.0% | 62,3 k € | -44.9% | 113,2 k € | +200.0% | 37,7 k € | +84.4% | 20,5 k € | -96.4% | 563,6 k € | +641.0% | 76,1 k € | +25.7% | 60,5 k € | +33.0% | 45,5 k € | +28.7% | 35,3 k € | -46.1% | 65,6 k € | +30.5% | 50,3 k € | +16.1% | 43,3 k € | |
| Debts | 571,4 k € | -1.9% | 582,4 k € | +10.9% | 525,4 k € | -2.9% | 541,0 k € | +1.0% | 535,5 k € | +9.9% | 487,5 k € | -5.9% | 518,3 k € | +2.2% | 507,4 k € | +268.9% | 137,5 k € | +15.1% | 119,5 k € | +28.1% | 93,3 k € | -8.8% | 102,3 k € | -91.5% | 1,2 M € | +485.8% | 204,7 k € | -14.6% | 239,6 k € | -12.3% | 273,4 k € | -11.4% | 308,5 k € | -19.9% | 385,0 k € | -8.6% | 421,3 k € | -7.7% | 456,5 k € | |
Private limited company · Ans · incorporated on 28/12/2000
Private limited company profitable and well capitalised. Cash position rising (+50.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MIVAPHARM is a Private limited company incorporated in 2000. Its main activity is: Buying and selling of own real estate. Its registered office is in Ans.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette